We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+17.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$2.26B
AUM Growth
+$384M
Cap. Flow
+$115M
Cap. Flow %
5.09%
Top 10 Hldgs %
22.4%
Holding
443
New
33
Increased
160
Reduced
64
Closed
38

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$39.7M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$14.6M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.1M
4
WLK icon
Westlake Corp
WLK
+$8.6M
5
BKNG icon
Booking.com
BKNG
+$6.85M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$26.3M
2
CELG
Celgene Corp
CELG
+$20.8M
3
TIF
Tiffany & Co.
TIF
+$8.44M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$7.14M
5
ROP icon
Roper Technologies
ROP
+$5.77M

Sector Composition

Rank Sector Weight
1 Healthcare 30.75%
2 Technology 20.83%
3 Consumer Discretionary 14.53%
4 Financials 9.34%
5 Miscellaneous 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARNA
251
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.22M 0.05%
26,500
– –
TAL icon
252
TAL Education Group
TAL
$6.52B
$1.21M 0.05%
25,000
– –
AMSC icon
253
American Superconductor
AMSC
$1.34B
$1.2M 0.05%
150,000
+15,000
+11% +$121K
IOVA icon
254
Iovance Biotherapeutics
IOVA
$4.24B
$1.2M 0.05%
43,000
– –
SLB icon
255
SLB Ltd
SLB
$80.4B
$1.18M 0.05%
29,300
+28,950
+8,271% +$1.03M
QQQ icon
256
Invesco QQQ Trust
QQQ
$474B
$1.18M 0.05%
5,545
– –
LNC icon
257
Lincoln National
LNC
$8.32B
$1.17M 0.05%
20,000
– –
PANW icon
258
Palo Alto Networks
PANW
$307B
$1.17M 0.05%
30,000
– –
WDAY icon
259
Workday
WDAY
$46B
$1.16M 0.05%
7,000
+3,600
+106% +$598K
NIU
260
Niu Technologies
NIU
$159M
$1.14M 0.05%
135,000
– –
MOMO
261
Hello Group
MOMO
$714M
$1.14M 0.05%
33,000
– –
MET icon
262
MetLife
MET
$62.4B
$1.12M 0.05%
22,000
– –
EDU icon
263
New Oriental
EDU
$8.95B
$1.12M 0.05%
9,000
– –
APD icon
264
Air Products & Chemicals
APD
$64.7B
$1.11M 0.05%
4,730
+1,400
+42% +$316K
COP icon
265
ConocoPhillips
COP
$170B
$1.1M 0.05%
16,900
– –
CIB icon
266
Grupo Cibest SA
CIB
$23.8B
$1.1M 0.05%
+20,000
New +$1.03M
IBB icon
267
iShares Biotechnology ETF
IBB
$10.3B
$1.08M 0.05%
9,000
-18,251
-67% -$2.04M
MU icon
268
Micron Technology
MU
$1.05T
$1.03M 0.05%
19,000
– –
INFY icon
269
Infosys
INFY
$45.8B
$1.03M 0.05%
100,000
-85,800
-46% -$863K
BMY.RT
270
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$972K 0.04%
+325,220
New +$846K
ENS icon
271
EnerSys
ENS
$6.15B
$950K 0.04%
+12,546
New +$869K
AJG icon
272
Arthur J. Gallagher & Co
AJG
$63.6B
$948K 0.04%
10,000
– –
TER icon
273
Teradyne
TER
$52B
$943K 0.04%
+13,540
New +$860K
NKTR icon
274
Nektar Therapeutics
NKTR
$2.28B
$923K 0.04%
2,853
-314
-10% -$91.1K
FNF icon
275
Fidelity National Financial
FNF
$11.7B
$902K 0.04%
20,800
– –
9 10
11
12 13

Similar funds

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
WI
WealthNavi Inc Shinagawa-Ku, Tokyo, Japan $12.8B AUM 19.73% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $12.6B AUM 41.69% 1-Year Est. Return

Erste Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Erste Asset Management held 443 positions worth $2.26B, up 20% from $1.88B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $115M of net new capital in Q4 2019, opening 33 new positions and adding to 160 existing holdings. Its largest new stake was Westlake Corp: 128,000 shares worth $8.83M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $26.3M trimmed.

  • Erste Asset Management's largest Q4 2019 buy was Westlake Corp: 128,000 shares worth $8.83M.
  • Erste Asset Management added most to Biogen in Q4 2019, an estimated $39.7M increase.
  • Erste Asset Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $26.3M.
  • Erste Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • Erste Asset Management's ten largest holdings make up 22% of its $2.26B portfolio in Q4 2019.
  • Erste Asset Management opened 33 new positions and closed 38 in Q4 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $2.26B.

Based on Erste Asset Management's 13F filing for Q4 2019, filed 22 Nov 2024.